These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. No increase of beta 2-glycoprotein I levels in patients with antiphospholipid antibodies. De Benedetti E, Reber G, Miescher PA, de Moerloose P. Thromb Haemost; 1992 Nov 10; 68(5):624. PubMed ID: 1455413 [No Abstract] [Full Text] [Related]
14. Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus. Puurunen M, Vaarala O, Julkunen H, Aho K, Palosuo T. Clin Immunol Immunopathol; 1996 Jul 10; 80(1):16-22. PubMed ID: 8674235 [Abstract] [Full Text] [Related]
15. Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing. Wong RC, Adelstein S, Gillis D, Favaloro EJ. Semin Thromb Hemost; 2005 Feb 10; 31(1):39-48. PubMed ID: 15706474 [Abstract] [Full Text] [Related]
17. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Matsuda J, Saitoh N, Gohchi K, Gotoh M, Tsukamoto M. Am J Hematol; 1994 Sep 10; 47(1):56-8. PubMed ID: 8042617 [Abstract] [Full Text] [Related]
18. Neither cell-surface nor soluble CD154 levels are associated with coronary artery disease in systemic lupus erythematosus. von Feldt JM, Latif S, Genin A, Cron RQ. J Rheumatol; 2008 Feb 10; 35(2):359-60. PubMed ID: 18260168 [No Abstract] [Full Text] [Related]
19. Revision of the Sapporo criteria for the antiphospholipid syndrome-- coming to grips with evidence and Thomas Bayes? Lackner KJ, Peetz D, von Landenberg P. Thromb Haemost; 2006 Jun 10; 95(6):917-9. PubMed ID: 16732366 [No Abstract] [Full Text] [Related]
20. [Primary antiphospholipid syndrome]. Popa A, Voinea L, Pop M, Stana D, Dascalu AM, Alexandrescu C, Ciuluvica R. Oftalmologia; 2008 Jun 10; 52(1):13-7. PubMed ID: 18714484 [Abstract] [Full Text] [Related] Page: [Next] [New Search]